Lv11
20 积分 2025-05-30 加入
Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
1小时前
待确认
The Treatment of Marginal Zone Lymphoma
10天前
已完结
Marginal-Zone Lymphomas
10天前
已完结
Marginal-Zone Lymphomas
17天前
已完结
Marginal-Zone Lymphomas
20天前
已完结
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
23天前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
1个月前
已完结
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system
1个月前
已完结
Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2个月前
已完结
皖公网安备34019202002308
